Predictors of postoperative performance status after surgical management of infratemporal fossa malignancies.
Anterolateral skull base
Cancer
Case series
Infratemporal fossa
Karnofsky performance status (KPS)
Quality of life
Surgery
Journal
Neurosurgical review
ISSN: 1437-2320
Titre abrégé: Neurosurg Rev
Pays: Germany
ID NLM: 7908181
Informations de publication
Date de publication:
29 Jun 2023
29 Jun 2023
Historique:
received:
13
05
2023
accepted:
19
06
2023
revised:
13
06
2023
medline:
3
7
2023
pubmed:
30
6
2023
entrez:
29
6
2023
Statut:
epublish
Résumé
Infratemporal fossa (ITF) tumors are difficult to access surgically due to anatomical constraints. Moreover, aggressive ITF carcinomas and sarcomas necessitate aggressive treatment strategies that, along with tumor-related symptoms, contribute to decreases in patient performance status. To assess factors that predict postoperative performance in patients undergoing surgery for ITF tumors. We reviewed medical records for all patients surgically treated for an ITF malignancy between January 1, 1999, and December 31, 2017, at our institution. We collected patient demographics, preoperative performance, tumor stage, tumor characteristics, treatment modalities, pathological data, and postoperative performance data. The 5-year survival rate was 62.2%. Higher preoperative Karnofsky Performance Status (KPS) score (n = 64; p < 0.001), short length of stay (p = 0.002), prior surgery at site (n = 61; p = 0.0164), and diagnosis of sarcoma (n = 62; p = 0.0398) were predictors of higher postoperative KPS scores. Percutaneous endoscopic gastrostomy (PEG) (n = 9; p = 0.0327), and tracheostomy tube placement (n = 20; p = 0.0436) were predictors of lower postoperative KPS scores, whereas age at presentation (p = 0.72), intracranial tumor spread (p = 0.8197), and perineural invasion (n = 40; p = 0.2195) were not. Male patients and patients with carcinomas showed the greatest decreases in KPS scores between pretreatment and posttreatment. Higher preoperative KPS score and short length of stay were the best predictors of higher postoperative KPS scores. This work provides treatment teams and patients with better information on outcomes for shared decision-making.
Identifiants
pubmed: 37386212
doi: 10.1007/s10143-023-02063-8
pii: 10.1007/s10143-023-02063-8
doi:
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
157Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Isolan GR, Rowe R, Al-Mefty O (2007) Microanatomy and surgical approaches to the infratemporal fossa: an anaglyphic three-dimensional stereoscopic printing study. Skull Base 17:285–302. https://doi.org/10.1055/s-2007-985193
doi: 10.1055/s-2007-985193
pubmed: 18330427
pmcid: 2095118
Joo W, Funaki T, Yoshioka F, Rhoton AL (2013) Microsurgical anatomy of the infratemporal fossa. Clin Anat 26:455–469. https://doi.org/10.1002/ca.22202
doi: 10.1002/ca.22202
pubmed: 23355316
Amit M, Bell D, Hunt PJ, Hanna E, Su SY, Kupferman M et al (2020) Surgical management of carcinomas of the infratemporal fossa and skull base: patterns of failure and predictors of long-term outcomes. J Neurosurg 134:1–7. https://doi.org/10.3171/2020.3.jns192630
doi: 10.3171/2020.3.jns192630
Hentschel SJ, Vora Y, Suki D, Hanna EY, DeMonte F (2010) Malignant tumors of the anterolateral skull base. Neurosurgery 66:102–112. https://doi.org/10.1227/01.NEU.0000362033.38035.25
doi: 10.1227/01.NEU.0000362033.38035.25
pubmed: 20023541
Sekhar LN, Schramm VL, Jones NF (1987) Subtemporal-preauricular infratemporal fossa approach to large lateral and posterior cranial base neoplasms. J Neurosurg 67:488–499. https://doi.org/10.3171/jns.1987.67.4.0488
doi: 10.3171/jns.1987.67.4.0488
pubmed: 3655886
Janecka IP (1995) Classification of facial translocation approach to the skull base. Otolaryngol Head Neck Surg 112:579–585. https://doi.org/10.1177/019459989511200412
doi: 10.1177/019459989511200412
pubmed: 7700665
Janecka IP, Sen CN, Sekhar LN, Arriaga M (1990) Facial translocation: a new approach to the cranial base. Otolaryngol Head Neck Surg 103:413–419. https://doi.org/10.1177/019459989010300312
doi: 10.1177/019459989010300312
pubmed: 2122371
Givi B, Liu J, Bilsky M, Mehrara B, Disa J, Pusic A et al (2013) Outcome of resection of infratemporal fossa tumors. Head Neck 35:1567–1572. https://doi.org/10.1002/HED
doi: 10.1002/HED
pubmed: 23322409
Vigano A, Dorgan M, Buckingham J, Bruera E, Suarez-Almazor ME (2000) Survival prediction in terminal cancer patients: a systematic review of the medical literature. Palliat Med 14:363–374. https://doi.org/10.1191/026921600701536192
doi: 10.1191/026921600701536192
pubmed: 11064783
Thongprasert S, Sanguanmitra P, Juthapan W, Clinch J (1999) Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care (BSC) versus BSC plus chemotherapy. Lung Cancer 24:17–24. https://doi.org/10.1016/S0169-5002(99)00017-3
doi: 10.1016/S0169-5002(99)00017-3
pubmed: 10403690
Mor V, Laliberte L, Morris J, Wiemann M (1984) The Karnofsky performance status scale. An examination of its reliability and validity in a research setting. Cancer 53:2002–2007
doi: 10.1002/1097-0142(19840501)53:9<2002::AID-CNCR2820530933>3.0.CO;2-W
pubmed: 6704925
Tassinari D, Montanari L, Maltoni M, Ballardini M, Piancastelli A, Musi M et al (2008) The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy. Support Care Cancer 16:359–370. https://doi.org/10.1007/s00520-007-0302-3
doi: 10.1007/s00520-007-0302-3
pubmed: 17629751
Barbot AC, Mussault P, Ingrand P, Tourani JM (2008) Assessing 2-month clinical prognosis in hospitalized patients with advanced solid tumors. J Clin Oncol 26:2538–2543. https://doi.org/10.1200/JCO.2007.14.9518
doi: 10.1200/JCO.2007.14.9518
pubmed: 18487571
Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH (1948) The use of the nitrogen mustards in the palliative treatment of carcinoma. Cancer 1:634–656. https://doi.org/10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L
doi: 10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L
Atkinson TM, Andreotti CF, Roberts KE, Saracino RM, Hernandez M, Basch E (2015) The level of association between functional performance status measures and patient-reported outcomes in cancer patients: a systematic review. Support Care Cancer 23:3645–3652. https://doi.org/10.1007/s00520-015-2923-2
doi: 10.1007/s00520-015-2923-2
pubmed: 26314706
pmcid: 4832926
Velanovich V, Wollner I (2011) Quality of life and performance status in patients with pancreatic and periampullary tumors. Int J Clin Oncol 16:401–407. https://doi.org/10.1007/s10147-011-0200-z
doi: 10.1007/s10147-011-0200-z
pubmed: 21347628
Schag CC, Heinrich RL, Ganz PA (1984) Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol 2:187–193. https://doi.org/10.1200/JCO.1984.2.3.187
doi: 10.1200/JCO.1984.2.3.187
pubmed: 6699671
Martin RC, Gerstenecker A, Nabors LB, Marson DC, Triebel KL (2015) Impairment of medical decisional capacity in relation to Karnofsky performance status in adults with malignant brain tumor. Neuro-Oncology Pract 2:13–19. https://doi.org/10.1093/nop/npu030
doi: 10.1093/nop/npu030
Gunawan PY, Islam A, July J, Patellongi I, Nasrum M, Aninditha T (2020) Karnofsky performance scale and neurological assessment of neuro-oncology scale as early predictor in glioma. Asian Pacific J Cancer Prev 21:3387–3392. https://doi.org/10.31557/apjcp.2020.21.11.3387
doi: 10.31557/apjcp.2020.21.11.3387
Gabrovsky N, Laleva M, Poptodorov G, Velinov N, Kamenova M, Kaneva R et al (2020) Impact of surgical treatment on the performance status of patients with high-grade gliomas. Neurol Res 42:1074–1079. https://doi.org/10.1080/01616412.2020.1802147
doi: 10.1080/01616412.2020.1802147
pubmed: 32892718
Chaichana K, Parker S, Olivi A, Quiñones-Hinojosa A (2010) A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme. J Neurosurg 112:997–1004. https://doi.org/10.3171/2009.9.JNS09805
doi: 10.3171/2009.9.JNS09805
pubmed: 19817542
Budrukkar A, Jalali R, Dutta D, Sarin R, Devlekar R, Parab S et al (2009) Prospective assessment of quality of life in adult patients with primary brain tumors in routine neurooncology practice. J Neurooncol 95:413–419. https://doi.org/10.1007/s11060-009-9939-8
doi: 10.1007/s11060-009-9939-8
pubmed: 19548070
Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS (2011) An extent of resection threshold for newly diagnosed glioblastomas: clinical article. J Neurosurg 115:3–8. https://doi.org/10.3171/2011.2.JNS10998
doi: 10.3171/2011.2.JNS10998
pubmed: 21417701
Agha RA, Sohrabi C, Mathew G, Franchi T, Kerwan A, O’Neill N et al (2020) The PROCESS 2020 guideline: updating consensus preferred reporting of case series in surgery (PROCESS) guidelines. Int J Surg 84:231–235. https://doi.org/10.1016/j.ijsu.2020.11.005
doi: 10.1016/j.ijsu.2020.11.005
pubmed: 33189880
Bigelow DC, Smith PG, Leonetti JP, Backer RL, Grubb RL, Kotapka MJ (1999) Treatment of malignant neoplasms of the lateral cranial base with the combined frontotemporal-anterolateral approach: five-year follow-up. Otolaryngol - Head Neck Surg 120:17–24. https://doi.org/10.1016/S0194-5998(99)70364-5
doi: 10.1016/S0194-5998(99)70364-5
pubmed: 9914544
Shah JP, Sundaresan N, Galicich J, Strong EW (1987) Craniofacial resections for tumors involving the base of the skull. Am J Surg 154:352–358. https://doi.org/10.1016/0002-9610(89)90003-2
doi: 10.1016/0002-9610(89)90003-2
pubmed: 3661836
L’Esperance HE, Kallogjeri D, Yousaf S, Piccirillo JF, Rich JT (2018) Prediction of mortality and morbidity in head and neck cancer patients 80 years of age and older undergoing surgery. Laryngoscope 128:871–877. https://doi.org/10.1002/lary.26858
doi: 10.1002/lary.26858
pubmed: 29105781
Perlow HK, Cassidy V, Farnia B, Kwon D, Awerbuch AW, Ciraula S et al (2019) Impact of performance status and comorbidity on palliative radiation treatment tolerance and end-of-life decision-making. Adv Radiat Oncol 4:127–133. https://doi.org/10.1016/j.adro.2018.09.002
doi: 10.1016/j.adro.2018.09.002
pubmed: 30706020
Chambless LB, Kistka HM, Parker SL, Hassam-Malani L, McGirt MJ, Thompson RC (2015) The relative value of postoperative versus preoperative Karnofsky performance scale scores as a predictor of survival after surgical resection of glioblastoma multiforme. J Neurooncol 121:359–364. https://doi.org/10.1007/s11060-014-1640-x
doi: 10.1007/s11060-014-1640-x
pubmed: 25344883
Mir T, Pond G, Greenspoon JN (2021) Outcomes in elderly patients with glioblastoma multiforme treated with short-course radiation alone compared to short-course radiation and concurrent and adjuvant temozolomide based on performance status and extent of resection. Curr Oncol 28:2399–2408. https://doi.org/10.3390/curroncol28040220
doi: 10.3390/curroncol28040220
pubmed: 34206775
pmcid: 8293260
Li H, Huang H, Zhang X, Wang Y, Ren X, Cui Y et al (2021) Postoperative long-term independence among the elderly with meningiomas: function evolution, determinant identification, and prediction model development. Front Oncol 11:1–11. https://doi.org/10.3389/fonc.2021.639259
doi: 10.3389/fonc.2021.639259
Brazil L, Thomas R, Laing R, Hines F, Guerrero D, Ashley S et al (1997) Verbally administered Barthel Index as functional assessment in brain tumour patients. J Neurooncol 34:187–192. https://doi.org/10.1023/A:1005710729748
doi: 10.1023/A:1005710729748
pubmed: 9210067
Noll KR, Bradshaw ME, Weinberg JS, Wefel JS (2018) Neurocognitive functioning is associated with functional independence in newly diagnosed patients with temporal lobe glioma. Neuro-Oncology Pract 5:184–193. https://doi.org/10.1093/nop/npx028
doi: 10.1093/nop/npx028
Muto J, Dezamis E, Rigaux-Viode O, Peeters S, Roux A, Zanello M et al (2018) Functional-based resection does not worsen quality of life in patients with a diffuse low-grade glioma involving eloquent brain regions: a prospective cohort study. World Neurosurg 113:e200–e212. https://doi.org/10.1016/j.wneu.2018.01.213
doi: 10.1016/j.wneu.2018.01.213
pubmed: 29432943
Starnoni D, Berthiller J, Idriceanu TM, Meyronet D, D’Hombres A, Ducray F et al (2018) Returning to work after multimodal treatment in glioblastoma patients. Neurosurg Focus 44:1–8. https://doi.org/10.3171/2018.3.FOCUS1819
doi: 10.3171/2018.3.FOCUS1819
Flores PM, Berbis J, Chinot O, Auquier P (2014) Assessing the quality of life among caregivers of patients with gliomas. Neuro-Oncology Pract 1:191–197. https://doi.org/10.1093/nop/npu027
doi: 10.1093/nop/npu027
Bayen E, Laigle-Donadey F, Prouté M, Hoang-Xuan K, Joël ME, Delattre JY (2017) The multidimensional burden of informal caregivers in primary malignant brain tumor. Support Care Cancer 25:245–253. https://doi.org/10.1007/s00520-016-3397-6
doi: 10.1007/s00520-016-3397-6
pubmed: 27624465
Finocchiaro CY, Petruzzi A, Lamperti E, Botturi A, Gaviani P, Silvani A et al (2012) The burden of brain tumor: a single-institution study on psychological patterns in caregivers. J Neurooncol 107:175–181. https://doi.org/10.1007/s11060-011-0726-y
doi: 10.1007/s11060-011-0726-y
pubmed: 21968946